CEO SUMMARY: Some diagnostic lab leaders and anatomic pathology practice owners may not immediately think that the elimination of a federal advisory panel should be on their radar. But the demise of the Clinical Laboratory Improvement Advisory Committee may cost labs by delaying timely decisions about CLIA updates and closing off a popular forum to […]
Lab Industry Fallout from CLIAC Termination
Laboratories will suffer from a lack of timely decisions, says CAP President Donald Karcher
- By Stephen Beale
- > From the Volume XXXII, No. 9 - June 23, 2025 Issue
- Tags: accreditation, ADLM, advisory panels, american society for clinical pathology, Anatomic pathology, Anthony Killeen MD PhD, ASCP, Association for Diagnostics and Laboratory Medicine, cap, CDC, Centers for Medicare and Medicaid Services, clia, CLIAC, CLIAC termination, Clinical Laboratory Improvement Advisory Committee, Clinical Laboratory Improvement Amendments of 1988, CMS, College of American Pathologists, Donald Karcher MD, Executive Order 14217, FDA, Federal Register, Food and Drug Administration, HHS, James Crawford MD PhD, laboratory-developed test, ldt, Northwell Health, Politico, proficiency testing, PT, quality assurance, Robert Kennedy Jr., US Centers for Disease Control and Prevention, US Department of Health and Human Services
